Insecticides (India) Ltd Reports 8% Revenue Growth in Q3FY26
03 February 2026, New Delhi: Insecticides (India) Limited (IIL) has announced its financial results for the quarter and nine months ended December 31, 2025.
Consolidated Financial Performance
Financial Performance Overview
During Q3FY26, IIL reported an 8% growth in revenue, primarily driven by a robust performance in the B2B segment. The B2C segment, however, remained under pressure due to macro industry headwinds, including erratic rainfall and a muted spraying season. Despite these challenges, the company continued its strategic focus on innovative marketing initiatives and deeper farmer engagement, aimed at reinforcing long-term brand equity and creating durable demand.
New product launches such as Sparcle, Centran, and Torry Super witnessed encouraging adoption among farmers. Gross profit margins moderated during the quarter, mainly due to a higher B2B mix and industry-led pressure on B2C margins, particularly against a high base in Q3FY25. Additionally, an increase in finance costs and depreciation impacted PAT growth in Q3FY26 compared to the same period last year.
Operational Highlights
IIL sustained a strong innovation-driven approach during 9MFY26 with the launch of five new products, further strengthening its product pipeline. The company also undertook aggressive demand generation initiatives, working closely with farmers across India through more than 25,000 farmer meetings and over 5,000 field days to demonstrate the benefits of adopting the latest technology-led solutions.
Management Commentary
Commenting on the performance, Mr. Rajesh Kumar Aggarwal, Managing Director, Insecticides (India) Ltd., said that the company reported a resilient performance in Q3FY26, delivering 8% revenue growth despite a challenging operating environment marked by industry-wide macro headwinds, erratic weather patterns, and a subdued spraying season. He noted that growth during the quarter was predominantly volume-led, driven by higher B2B contribution, while B2C demand remained muted amid broader sectoral pressures. According to him, margin compression during the quarter is transitory, driven by industry headwinds and a high base effect, and is expected to improve over time.
He further stated that the company continued to invest in long-term brand building, with encouraging outcomes from recent launches such as Sparcle, an advanced chemistry insecticide from Corteva, and Torry Super, developed through in-house R&D. These were supported by aggressive demand generation activities and deep farmer engagement. Alongside this, IIL strengthened its organizational capabilities, focused on internal training initiatives, and accelerated its phygital farmer outreach.
Also Read: Mastering VIXERAN® Application: Top Tips for Optimal Results
Global Agriculture is an independent international media platform covering agri-business, policy, technology, and sustainability. For editorial collaborations, thought leadership, and strategic communications, write to pr@global-agriculture.com
